JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, cilt.97, sa.8, ss.1120-1126, 2005 (SCI-Expanded)
Objectives: To investigate the prevalence of anticyclic citrullinated peptide (anti-CCP) in patients with advanced rheumatoid arthritis (RA) and to compare it with those in control subjects. Further, to study the relation between the anti-CCP and the disease activity parameters in these patients.